XML 73 R56.htm IDEA: XBRL DOCUMENT v3.25.4
RESTRUCTURING AND EXIT ACTIVITIES COSTS (Tables)
 12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs These charges are reflected in the following captions in the accompanying Condensed Consolidated Statements of Operations as follows:
Year Ended
(in thousands)December 31, 2025December 31, 2024December 31, 2023
Total cost of sales (a)
$1,034 $(785)$1,401 
Selling, general and administrative
5,855 370 5,598 
Research and development
1,561 385 1,243 
Total
$8,450 $(30)$8,242 
(a) Only restructuring costs recorded to cost of sales have been included in our reported segment results, as gross profit is our measure of segment profitability. For 2025, $0.5 million of severance and termination costs recorded to cost of sales are included in Healthcare and $0.5 million are included in Industrial. All severance and termination costs recorded to costs of sales for 2024 and 2023 are included in our Healthcare segment and, accordingly, are reflected in the Healthcare segment's reported gross profit. There were no facility termination costs or impairment costs included in the amounts reported for consolidated or segment cost of sales. See Note 19 for the reported gross profit for each of our reportable segments.
The activity in the restructuring accrual related to the 2025 and 2023 Restructuring Plans was as follows:
(in thousands)December 31, 2025December 31, 2024
Balance at beginning of period
$487 $3,933 
Costs incurred and other adjustments to accrued liability during the period
8,450 (30)
Amounts settled with cash
(7,707)(3,416)
Balance at the end of period
$1,230 $487